Johnson & Johnson asked the Food and Drug Administration to authorize a booster dose of its Covid-19 vaccine for people 18 and older
"A booster of our COVID-19 vaccine increases levels of protection for those who have received our single-shot vaccine to 94 percent," said Mathai Mammen, global head of research and development at J&J's Janssen subsidiary. “At the same time, we continue to recognize that a single-shot COVID-19 vaccine that provides strong and long-lasting protection remains a crucial component to vaccinating the global population.
The timing of the meeting is unusual: FDA does not normally announce an advisory panel will gather to discuss an application before one is filed. But the Biden administration is pushing to roll out Covid-19 boosters quickly this fall to prevent a fall or winter surge as temperatures grow colder and people head indoors, including for the holiday season.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Johnson & Johnson asks FDA to authorize Covid-19 vaccine booster shotsJohnson & Johnson has asked the FDA to authorize booster shots for its coronavirus vaccine, but has left it up to the FDA and the US Centers for Disease Control and Prevention to decide just who should get their boosters and when.
Consulte Mais informação »
Johnson & Johnson Seeks U.S. Clearance For COVID-19 Vaccine Booster DosesJ&J said it filed a request with the FDA to authorize boosters for people 18 and older who previously received the company's one-shot vaccine.
Consulte Mais informação »
Former FDA commissioner says COVID-19 vaccine included in childhood immunization schedule is 'inevitable'Former Food and Drug Administration Commissioner Dr. Scott Gottlieb said he thinks it's 'inevitable that the COVID-19 vaccine is going to be incorporated into the childhood immunization schedule' in an interview on CBS's 'Face The Nation' Sunday.
Consulte Mais informação »
Johnson & Johnson files for authorization of Covid vaccine boosterThe vaccine maker said an additional second shot of its vaccine given about two months after the first increased its effectiveness to 94 percent, compared with 70 percent protection with the single dose.
Consulte Mais informação »
India's Divi's Labs hits record high on Merck's positive trial data for COVID-19 drugShares of India's Divi's Laboratories Ltd , which makes the main ingredient of Merck & Co's experimental antiviral pill, soared 10% on Monday, after the pharmaceutical giant reported positive clinical trial results for the drug.
Consulte Mais informação »